These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29476216)

  • 21. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
    Poultsides GA; Bao F; Servais EL; Hernandez-Boussard T; DeMatteo RP; Allen PJ; Fong Y; Kemeny NE; Saltz LB; Klimstra DS; Jarnagin WR; Shia J; D'Angelica MI
    Ann Surg Oncol; 2012 Sep; 19(9):2797-804. PubMed ID: 22476753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting chemotherapeutic response for colorectal liver metastases using relative tumor enhancement of gadoxetic acid disodium-enhanced magnetic resonance imaging.
    Murata S; Matsushima S; Sato Y; Yamaura H; Kato M; Hasegawa T; Muro K; Inaba Y
    Abdom Radiol (NY); 2018 Dec; 43(12):3301-3306. PubMed ID: 29666951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategies and outcome of surgery for synchronous colorectal liver metastases.
    Reding D; Pestalozzi BC; Breitenstein S; Stupp R; Clavien PA; Slankamenac K; Samaras P
    Swiss Med Wkly; 2017; 147():w14486. PubMed ID: 28871569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.
    Lau LF; Murone C; Williams DS; Standish R; Lee ST; Christophi C; Scott AM; Muralidharan V
    ANZ J Surg; 2018 Mar; 88(3):E108-E113. PubMed ID: 27452367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
    Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
    Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
    Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
    HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.
    Jia G; O'Dell C; Heverhagen JT; Yang X; Liang J; Jacko RV; Sammet S; Pellas T; Cole P; Knopp MV
    Radiology; 2008 Sep; 248(3):901-9. PubMed ID: 18710983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases.
    Zhao J; Sawo P; Rensen SS; Rouflart MMJ; Winstanley A; Vreuls CPH; Verheij J; van Mierlo KMC; Lodewick TM; van Woerden V; van Tiel FH; van Dam RM; Dejong CHC; Olde Damink SWM
    HPB (Oxford); 2018 Feb; 20(2):147-154. PubMed ID: 28969959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
    Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
    Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Krishnamurthy A; Kankesan J; Wei X; Nanji S; Biagi JJ; Booth CM
    Eur J Surg Oncol; 2017 Feb; 43(2):364-371. PubMed ID: 27727025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases.
    Amptoulach S; Gross G; Sturesson C; Rissler P; Kalaitzakis E
    Scand J Surg; 2017 Dec; 106(4):311-317. PubMed ID: 28737112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
    Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
    Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Pikoulis E; Petrou A; Agrogiannis G; Petrides C; Papakonstandinou I; Papalambros A; Aggelou A; Kavatzas N; Liakakos T; Felekouras E
    Sci Rep; 2017 May; 7(1):2058. PubMed ID: 28515480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
    Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
    Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
    Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
    Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.